APA

Plachouras D., Karvanen M., Friberg L. E., Papadomichelakis E., Antoniadou A., Tsangaris I., Karaiskos I., Poulakou G., Kontopidou F., Armaganidis A., Cars O. & Giamarellou H. (20091019). Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. : Antimicrobial agents and chemotherapy.

Chicago

Plachouras D, Karvanen M, Friberg L E, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O and Giamarellou H. 20091019. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. : Antimicrobial agents and chemotherapy.

Harvard

Plachouras D., Karvanen M., Friberg L. E., Papadomichelakis E., Antoniadou A., Tsangaris I., Karaiskos I., Poulakou G., Kontopidou F., Armaganidis A., Cars O. and Giamarellou H. (20091019). Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. : Antimicrobial agents and chemotherapy.

MLA

Plachouras D, Karvanen M, Friberg L E, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O and Giamarellou H. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. : Antimicrobial agents and chemotherapy. 20091019.